V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003379 | 210011618 | 1.66 | 58.05 | null | 2017-06-06 | 2017-06-15 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101641620 |
| 210003380 | 210011619 | 1.66 | 94.5 | Neo-adjuvant (N) | 2019-10-15 | 2019-10-26 | Palbociclib | 02 | N | CARBOPLATIN + DOCETAXEL | 100381088 |
| 210003381 | 210011620 | 1.59 | 85 | Palliative (P) | null | 2019-02-21 | Capecitabine | 02 | N | CAPECITABINE | 101838247 |
| 210003388 | 210011622 | 1.68 | 55.3 | Palliative (P) | 2017-07-20 | 2017-08-03 | null | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101361613 |
| 210003389 | 210011623 | 1.75 | 0 | Adjuvant (A) | 2017-05-22 | 2017-05-31 | CARBO + DOCETAXEL + TRASTUZUMAB | null | N | ABEMACICLIB + FULVESTRANT | 100808778 |
| 210003392 | 210011624 | 1.55 | 76.1 | Adjuvant (A) | null | 2019-10-21 | Doce + Pertuzumab + Trastuz IV Load | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100182714 |
| 210003393 | 210011625 | 1.69 | 86.7 | Palliative (P) | 2019-01-02 | 2019-04-04 | Capecitabine | 02 | N | CAPECITABINE | 101536249 |
| 210003395 | 210011626 | null | 60.8 | null | 2020-04-26 | 2020-04-26 | null | null | null | TRIAL UNSPECIFIED | 100942361 |
| 210003396 | 210011627 | null | 70.2 | Adjuvant (A) | 2018-07-21 | 2018-07-21 | FEC + DOCETAXEL | 02 | null | TRASTUZUMAB EMTANSINE | 101333374 |
| 210003400 | 210011628 | 1.66 | null | Palliative (P) | 2020-01-10 | 2020-01-30 | VINORELBINE | 02 | N | VINORELBINE | 101441451 |
| 210003401 | 210011629 | 1.85 | 54.05 | null | 2020-10-22 | 2021-02-06 | Capecitabine | 02 | null | CAPECITABINE | 100195159 |
| 210003402 | 210011630 | null | 66 | null | 2021-07-27 | 2021-08-29 | PACLITAXEL + TRASTUZUMAB | 02 | null | PACLITAXEL + TRASTUZUMAB | 101799200 |
| 210003403 | 210011631 | null | 74.8 | Adjuvant (A) | 2021-10-20 | 2022-01-07 | Eribulin | 02 | N | ERIBULIN | 100277269 |
| 210003404 | 210011632 | 1.66 | 67.95 | Palliative (P) | 2020-03-06 | 2020-06-15 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100247433 |
| 210003405 | 210011633 | 1.46 | 59.8 | null | 2019-02-15 | 2019-03-09 | Olaparib | null | null | TRASTUZUMAB DERUXTECAN | 101204735 |
| 210003407 | 210011634 | null | null | null | 2021-09-12 | 2021-10-06 | DOCETAXEL + TRASTUZUMAB | null | null | CARBOPLATIN + DOCETAXEL | 101465817 |
| 210003410 | 210011635 | 1.59 | 110 | Curative (C) | 2018-06-21 | 2018-08-31 | null | N | N | LETROZOLE + PALBOCICLIB | 100876739 |
| 210003415 | 210011637 | 1.85 | 73 | Neo-adjuvant (N) | null | 2017-12-12 | Capecitabine | 02 | N | CAPECITABINE | 100289053 |
| 210003416 | 210011638 | 1.58 | 62.5 | Palliative (P) | 2020-03-08 | 2020-03-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101247313 |
| 210003418 | 210011640 | 1.61 | 83.35 | 03 | 2017-09-16 | 2017-10-22 | Capecitabine | 02 | N | CAPECITABINE | 100692735 |
| 210003421 | 210011641 | 1.61 | 54.55 | Adjuvant (A) | 2021-01-26 | 2021-01-26 | CARBOPLATIN + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101291223 |
| 210003423 | 210011643 | null | null | null | null | 2021-01-15 | Epirubicin (weekly) | 02 | null | OLAPARIB | 100293313 |
| 210003424 | 210011644 | 1.61 | 96.1 | Adjuvant (A) | 2019-03-10 | 2019-08-25 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100219252 |
| 210003425 | 210011645 | 1.63 | 83.2 | Neo-adjuvant (N) | null | 2020-11-04 | null | 02 | N | PALBOCICLIB | 100143422 |
| 210003427 | 210011647 | 1.54 | 66 | null | null | 2016-10-26 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101337925 |
| 210003428 | 210011648 | 1.66 | 82.9 | null | 2020-10-03 | 2020-12-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100592120 |
| 210003429 | 210011649 | 1.61 | 75.8 | Neo-adjuvant (N) | 2018-11-24 | 2018-11-24 | ABEMACICLIB + FULVESTRANT | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100147183 |
| 210003430 | 210011650 | 1.57 | 80.5 | Adjuvant (A) | 2018-05-08 | 2018-10-16 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100944278 |
| 210003432 | 210011652 | 0 | 70.9 | Adjuvant (A) | 2021-12-08 | 2021-12-10 | EC | null | N | EC | 101833996 |
| 210003433 | 210011653 | 1.63 | 65.6 | null | 2015-10-24 | 2016-03-07 | null | N | null | NAB-PACLITAXEL | 101385512 |
| 210003434 | 210011654 | 1.68 | 98.2 | Neo-adjuvant (N) | 2022-02-04 | 2022-02-11 | null | 02 | N | ABEMACICLIB + FULVESTRANT | 100341751 |
| 210003435 | 210011655 | 1.64 | null | null | 2020-08-03 | 2020-09-16 | CARBOPLATIN | 02 | Y | CARBOPLATIN | 101535177 |
| 210003436 | 210011656 | null | null | Adjuvant (A) | 2019-08-22 | 2019-08-24 | Capecitabine | null | N | CAPECITABINE | 100136553 |
| 210003437 | 210011657 | null | null | Adjuvant (A) | 2016-04-06 | 2018-09-20 | null | 02 | null | CAPECITABINE + VINORELBINE | 100114068 |
| 210003439 | 210011658 | 1.66 | null | Adjuvant (A) | 2018-01-22 | 2020-01-01 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100457558 |
| 210003440 | 210011659 | 1.55 | 84.3 | Curative (C) | 2019-08-13 | 2019-09-14 | null | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101566652 |
| 210003445 | 210011662 | 1.68 | 84 | Palliative (P) | 2021-02-11 | 2021-02-26 | Capecitabine | 02 | N | CAPECITABINE | 101866837 |
| 210003447 | 210011663 | null | 74.5 | Palliative (P) | 2020-07-27 | 2020-07-27 | null | 02 | null | TRIAL UNSPECIFIED | 101426523 |
| 210003449 | 210011664 | 1.57 | 95.5 | Neo-adjuvant (N) | 2021-11-19 | 2021-11-28 | Capecitabine | null | N | CAPECITABINE | 100247069 |
| 210003457 | 210011668 | 1.69 | 88.2 | 03 | null | 2021-02-03 | Eribulin | 02 | N | ERIBULIN | 100233095 |
| 210003460 | 210011669 | 1.66 | 97.1 | null | 2019-03-04 | 2019-03-11 | null | N | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 101755372 |
| 210003463 | 210011671 | 1.78 | 62.4 | null | 2021-07-22 | 2021-09-25 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100494571 |
| 210003464 | 210011672 | 1.47 | 88.6 | null | null | 2018-07-21 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101854779 |
| 210003467 | 210011673 | 1.71 | 76.85 | null | 2020-06-27 | 2021-08-29 | TRASTUZUMAB EMTANSINE | 02 | null | PALBOCICLIB | 101178524 |
| 210003469 | 210011675 | null | 63.2 | null | 2018-07-19 | 2018-08-01 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100346754 |
| 210003471 | 210011676 | 1.66 | 95.5 | Adjuvant (A) | 2016-02-01 | 2018-08-04 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100558104 |
| 210003473 | 210011678 | 1.66 | 72 | null | 2017-06-12 | 2017-06-12 | Paclitaxel+Trastuzumab wkly Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 100851270 |
| 210003483 | 210011681 | 1.6 | 118.8 | Adjuvant (A) | 2021-07-04 | 2021-07-27 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100054786 |
| 210003485 | 210011683 | 1.65 | 56 | Palliative (P) | null | 2019-07-02 | null | 02 | N | TRIAL UNSPECIFIED | 101283748 |
| 210003490 | 210011685 | null | 54.2 | null | 2019-09-14 | 2019-12-20 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100177487 |